British Journal of Cancer - Table of Contents alert Volume 112 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 112, Issue 8 (1301-1420) Published online 14 April 2015 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Clinical Studies Top Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer M Gharaibeh, A McBride, J L Bootman and I Abraham Br J Cancer 2015 112: 1301-1305; advance online publication, March 19, 2015; 10.1038/bjc.2015.65 Abstract | Full Text Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study U Bork, N N Rahbari, S Schölch, C Reissfelder, C Kahlert, M W Büchler, J Weitz and M Koch Br J Cancer 2015 112: 1306-1313; advance online publication, March 31, 2015; 10.1038/bjc.2015.88 Abstract | Full Text Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial M Verstraete, A Debucquoy, J Dekervel, J van Pelt, C Verslype, E Devos, G Chiritescu, K Dumon, A D'Hoore, O Gevaert, X Sagaert, E Van Cutsem and K Haustermans Br J Cancer 2015 112: 1314-1325; advance online publication, March 17, 2015; 10.1038/bjc.2015.93 Abstract | Full Text The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial A P Algazi, E Cha, S M Ortiz-Urda, T McCalmont, B C Bastian, J Hwang, M H Pampaloni, S Behr, K Chong, B Cortez, A Quiroz, F Coakley, S Liu and A I Daud Br J Cancer 2015 112: 1326-1331; advance online publication, March 31, 2015; 10.1038/bjc.2014.541 Abstract | Full Text Translational Therapeutics Top Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer S Sun, X Liang, X Zhang, T Liu, Q Shi, Y Song, Y Jiang, H Wu, Y Jiang, X Lu and D Pang Br J Cancer 2015 112: 1332-1339; advance online publication, March 31, 2015; 10.1038/bjc.2015.114 Abstract | Full Text Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer K L Mahon, H-M Lin, L Castillo, B Y Lee, M Lee-Ng, M D Chatfield, K Chiam, S N Breit, D A Brown, M P Molloy, G M Marx, N Pavlakis, M J Boyer, M R Stockler, R J Daly, S M Henshall and L G Horvath Br J Cancer 2015 112: 1340-1348; advance online publication, March 31, 2015; 10.1038/bjc.2015.74 Abstract | Full Text Molecular Diagnostics Top Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye L J Melchers, M F Mastik, B Samaniego Cameron, B A C van Dijk, G H de Bock, B F A M van der Laan, B van der Vegt, E J M Speel, J L N Roodenburg, M J H Witjes and E Schuuring Br J Cancer 2015 112: 1349-1357; advance online publication, March 17, 2015; 10.1038/bjc.2015.99 Abstract | Full Text HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53 D Meulendijks, N B Tomasoa, L Dewit, P H M Smits, R Bakker, M-L F van Velthuysen, E H Rosenberg, J H Beijnen, J H M Schellens and A Cats Br J Cancer 2015 112: 1358-1366; 10.1038/bjc.2015.20 Abstract | Full Text miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway Z Zhu, Y Xu, J Zhao, Q Liu, W Feng, J Fan and P Wang Br J Cancer 2015 112: 1367-1375; advance online publication, March 17, 2015; 10.1038/bjc.2015.102 Abstract | Full Text Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients M Mizuno, H Kajiyama, K Shibata, K Mizuno, M Kawai, T Nagasaka and F Kikkawa Br J Cancer 2015 112: 1376-1383; advance online publication, March 24, 2015; 10.1038/bjc.2015.97 Abstract | Full Text MIC-1/GDF15 in Barrett’s oesophagus and oesophageal adenocarcinoma O M Fisher, A J Levert-Mignon, S J Lord, K K M Lee-Ng, N K Botelho, D Falkenback, M L Thomas, Y V Bobryshev, D C Whiteman, D A Brown, S N Breit and R V Lord Br J Cancer 2015 112: 1384-1391; advance online publication, March 17, 2015; 10.1038/bjc.2015.100 Abstract | Full Text Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes C P Kratz, L Franke, H Peters, N Kohlschmidt, B Kazmierczak, U Finckh, A Bier, B Eichhorn, C Blank, C Kraus, J Kohlhase, S Pauli, G Wildhardt, K Kutsche, B Auber, A Christmann, N Bachmann, D Mitter, F W Cremer, K Mayer, C Daumer-Haas, C Nevinny-Stickel-Hinzpeter, F Oeffner, G Schlüter, M Gencik, B Überlacker, C Lissewski, I Schanze, M H Greene, C Spix and M Zenker Br J Cancer 2015 112: 1392-1397; advance online publication, March 5, 2015; 10.1038/bjc.2015.75 Abstract | Full Text Genetics and Genomics Top Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum A Matsubara, R Ogawa, H Suzuki, I Oda, H Taniguchi, Y Kanai, R Kushima and S Sekine Br J Cancer 2015 112: 1398-1404; advance online publication, March 24, 2015; 10.1038/bjc.2015.104 Abstract | Full Text The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial F Fitzal, M Filipits, M Rudas, R Greil, O Dietze, H Samonigg, S Lax, W Herz, P Dubsky, R Bartsch, R Kronenwett and M Gnant on behalf of the Austrian Breast and Colorectal Cancer Study group (ABCSG) Br J Cancer 2015 112: 1405-1410; advance online publication, March 24, 2015; 10.1038/bjc.2015.98 Abstract | Full Text Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients S Q Wong, A Fellowes, K Doig, J Ellul, T J Bosma, D Irwin, R Vedururu, A Y-C Tan, J Weiss, K S Chan, M Lucas, D M Thomas, A Dobrovic, J P Parisot and S B Fox Br J Cancer 2015 112: 1411-1420; advance online publication, March 5, 2015; 10.1038/bjc.2015.80 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.